Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
P04467
NCT00539968
Last Modified:
12/27/2004
 
First Published:
8/24/2003
2.
Phase I Study of Lonafarnib, Trastuzumab (Herceptin®), and Paclitaxel in Patients With HER2/neu-Overexpressing Stage IIIB, IIIC, or IV Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other, Pharmaceutical / Industry
EORTC-16023-10051
SPRI-P01900, NCT00068757
Last Modified:
8/23/2007
 
First Published:
4/23/2004
3.
Phase I Study of Lonafarnib and Temozolomide in Patients With Recurrent Primary Supratentorial Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Over 18
Other, Pharmaceutical / Industry
EORTC-16027
EORTC-26023, SPRI-P03174, NCT00083096
4.
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Active
18 and over
Other
174-2004
EU841-03, NCT00288444
5.
PH I Addition of Farnesyl Transferase Inhibitor to Temo for Pts w Gr 3 & 4 Malignant Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
00005027
7009, NCT00612651
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute